Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 1.00 |
| ▸ | MAOA | P21397 | 11/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | AR | P10275 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13907659 | 0.89 | MAOB (0.80) | MAOBMAOAMCL1AR | |
| SCHEMBL3961581 | 0.85 | MAOA (0.73) | MAOBMAOAMCL1ALDH1A1KDM4E | |
| SCHEMBL7256911 | 0.83 | MAOA (0.71) | MAOBMAOAMCL1ALDH1A1KDM4E | |
| SCHEMBL9174096 | 0.83 | MAOA (0.71) | MAOBMAOAMCL1ALDH1A1KDM4E | |
| SCHEMBL22749185 | 0.82 | MAOB (0.70) | MAOBMAOAMCL1AR | |
| SCHEMBL12949048 | 0.82 | MAOB (1.00) | MAOBMAOAALDH1A1KDM4EMAPT | |
| SCHEMBL30360762 | 0.82 | MAOB (0.70) | MAOBMAOAMCL1KDM4EMAPT | |
| SCHEMBL20511089 | 0.82 | MAOB (0.70) | MAOBMAOAMCL1KDM4EMAPT | |
| SCHEMBL522618 | 0.81 | MAOB (0.68) | MAOBMAOAMCL1KDM4EMAPT | |
| SCHEMBL21878993 | 0.78 | MAOB (0.64) | MAOBMAOAMCL1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12129381-B1 | Single vessel solvent based method for making a Zn/Cu composite | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-10-29 | — | — | US | disclosed |
| US-20240336778-A1 | SINGLE VESSEL SOLVENT BASED METHOD FOR MAKING A ZN/CU COMPOSITE | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-10-10 | — | — | US | disclosed |
| US-12031043-B2 | Method for synthesizing a micro/nanosphere-containing composite | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-07-09 | — | — | US | disclosed |
| US-11827792-B2 | Wastewater purification composition for organic dyes | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-11-28 | — | — | US | disclosed |
| US-20230279232-A1 | WASTEWATER PURIFICATION COMPOSITION FOR ORGANIC DYES | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-09-07 | — | — | US | disclosed |
| US-11667793-B2 | Photosensitizer composite and uses thereof | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-06-06 | — | — | US | disclosed |
| US-11661516-B2 | Solar light antibactertal agent | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-05-30 | — | — | US | disclosed |
| US-20230041590-A1 | PHOTOSENSITIZER COMPOSITE AND USES THEREOF | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-02-09 | — | — | US | disclosed |
| US-20230028656-A1 | SOLAR LIGHT ANTIBACTERIAL AGENT | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-01-26 | — | — | US | disclosed |
| US-20230002617-A1 | METHOD FOR SYNTHESIZING A MICRO/NANOSPHERE-CONTAINING COMPOSITE | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-01-05 | — | — | US | disclosed |
| EP-1644336-A1 | NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN | FIBROGEN, INC. (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20040254215-A1 | Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders | FIBROGEN, INC. | 2004-12-16 | — | — | US | disclosed |
| WO-2004108681-A1 | NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND THEIR USE IN INCREASING ENDOGENOUS ERYTHROPOIETIN | FIBROGEN, INC. (US) | 2004-12-16 | — | — | WO | disclosed |
| US-5703229-A | ALUMINUM PHTHALOCYANINE SUBSTITUTED WITH POLYESTER REACTIVE GROUPS; TAGGING THERMOPLASTIC WASTES FOR RECYCLING | EASTMAN CHEMICAL COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| US-5525516-A | DISSOLVING NEAR INFRARED FLUORESCING COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1996010620-A1 | METHOD FOR TAGGING PETROLEUM PRODUCTS | EASTMAN CHEMICAL COMPANY (US) | 1996-04-11 | — | — | WO | disclosed |
| US-5461136-A | Thermoplastic condensation polymer having copolymerized therein one or more near infrared fluorescing compounds | EASTMAN CHEMICAL COMPANY (US) | 1995-10-24 | — | — | US | disclosed |
| US-5397819-A | Phthalocyanines, naphthalocyanines, sqarines; detectable when exposed to specified wavelength limits of electromagnetic radiation; recycling of wastes | EASTMAN CHEMICAL COMPANY (US) | 1995-03-14 | — | — | US | disclosed |
| US-H477-H | Monolayer-forming substituted phthalocyanine compounds and method of preparation thereof | UNITED STATES OF AMERICA (US) | 1988-06-07 | — | — | US | disclosed |
| US-4636767-A | Mixed semiconductor film device for monitoring gases | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1987-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254215-A1 | Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders | EPOR, HIF1AN, HIF1A | MAOB 2718/4885MAOA 3338/4885MCL1 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.